Stocks
GoodRx Holdings (GDRX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 172.6% | 365.3% | 259.2% | 259.2% | 239.3% | 214.9% | |||
| Changes by years, y/y, % | -337pp | +193pp | -106pp | 0pp | -20pp | -28.4% | |||
GoodRx Holdings. R&D/CAPEX, %
GoodRx Holdings. R&D/CAPEX, changes, pp
GoodRx Holdings (GDRX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 230.3% | 209.1% | 290.3% | 245.0% | 150.5% | 214.9% | ||
| Changes by years, y/y, % | -52pp | -49pp | +29pp | +4pp | -80pp | |||
| Changes by quarters, q/q, % | -10pp | -21pp | +81pp | -45pp | -95pp | |||
